Document is current
Any future updates will be listed below
-
Authors
Campbell, Thomas M. https://orcid.org/0000-0003-4449-8229
Campbell, Erin K.
Culakova, Eva
Blanchard, Lisa M.
Wixom, Nellie
Guido, Joseph J.
Fetten, James
Huston, Alissa
Shayne, Michelle
Janelsins, Michelle C.
Mustian, Karen M.
Moore, Richard G.
Peppone, Luke J.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03045289 at ClinicalTrials.govDocuments that mention this clinical trial
A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomes
https://doi.org/10.1007/s10549-024-07284-z
A whole-food, plant-based dietary intervention and cognitive function in women with metastatic breast cancer.
https://doi.org/10.1200/jco.2023.41.16_suppl.e24160
A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes
https://doi.org/10.1007/s10549-024-07266-1
-
Funding
Funding for this research was provided by:
Highland Hospital Foundation
US National Institutes of Health (UG1-CA189961)
- License Information
-
More Information
Article History
Received: 11 October 2023
Accepted: 19 January 2024
First Online: 6 March 2024
Declarations
:
: This study was conducted in accordance with the U.S. Common Rule. The study protocol was approved by the University of Rochester Research Subject Review Board (ClinicalTrials.gov identifier: NCT03045289; registration February 7, 2017). Written informed consent was obtained from all participants.
: Not applicable.
: TMC: Royalties from general interest books about plant-based nutrition (Benbella Books, Penguin Random House) and income from a lifestyle medicine practice, Thomas M. Campbell, MD PLLC; EKC: Conflicts of spouse (TMC); AH: MJH Healthcare Holdings (OncLive), Mediflix (Skipta/Informa); RGM: Consultant for Fujirebio Diagnostics. Research funding from Angle plc. The rest of the authors declare no competing interests.
